Liver myofibroblasts from hepatitis B related liver failure patients may regulate natural killer cell function via PGE2

Journal of Translational Medicine

Volumn 12, Issue 1, 2014, Pages

  Zhang, Min ^a   Wang, Fenglan ^b,c   Chong, Yutian ^a   Tai, Qiang ^d   Zhao, Qiyi ^a   Zheng, Yubao ^a   Peng, Liang ^a   Lin, Shumei ^b   Gao, Zhiliang ^a  

^a THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^c Xi'an Eighth Hospital   (China)

^d THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Hepatitis B; Immune mediated liver injury; Liver failure; Liver myofibroblasts; Natural killer cell

Indexed keywords

INTERLEUKIN 2; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR; PROSTAGLANDIN E2;

ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DOWN REGULATION; FLOW CYTOMETRY; HEPATITIS B; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LIVER FAILURE; LYMPHOCYTE FUNCTION; MYOFIBROBLAST; NATURAL KILLER CELL; PATHOGENESIS; IMMUNOLOGY; LIVER; METABOLISM; PATHOLOGY;

DINOPROSTONE; HEPATITIS B; HUMANS; KILLER CELLS, NATURAL; LIVER; MYOFIBROBLASTS;

EID: 84920852310     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/s12967-014-0308-9     Document Type: Article

References (45)

1. Laleman W, Wilmer A, Evenepoel P, Verslype C, Fevery J, Nevens F: Review article: non-biological liver support in liver failure. Aliment Pharmacol Ther 2006, 23:351-363.
2. Wu Z, Han M, Chen T, Yan W, Ning Q: Acute liver failure: mechanisms of immune-mediated liver injury. Liver Int 2010, 30:782-794.
3. Laleman W, Verbeke L, Meersseman P, Wauters J, van Pelt J, Cassiman D, Wilmer A, Verslype C, Nevens F: Acute-on-chronic liver failure: current concepts on definition, pathogenesis, clinical manifestations and potential therapeutic interventions. Expert Rev Gastroenterol Hepatol 2011, 5:523-537. quiz 537.
4. Liu Q, Liu Z, Wang T, Wang Q, Shi X, Dao W: Characteristics of acute and sub-acute liver failure in China: nomination, classification and interval. J Gastroenterol Hepatol 2007, 22:2101-2106.
5. Trinchieri G: Biology of natural killer cells. Adv Immunol 1989, 47:187-376.
6. Cerwenka A, Lanier LL: Natural killer cells, viruses and cancer. Nat Rev Immunol 2001, 1:41-49.
7. French AR, Yokoyama WM: Natural killer cells and viral infections. Curr Opin Immunol 2003, 15:45-51.
8. Nakatani K, Kaneda K, Seki S, Nakajima Y: Pit cells as liver-associated natural killer cells: morphology and function. Med Electron Microsc 2004, 37:29-36.
9. Mackay IR: Hepatoimmunology: a perspective. Immunol Cell Biol 2002, 80:36-44.
10. Gao B, Radaeva S, Park O: Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases. J Leukoc Biol 2009, 86:513-528.
11. Ochi M, Ohdan H, Mitsuta H, Onoe T, Tokita D, Hara H, Ishiyama K, Zhou W, Tanaka Y, Asahara T: Liver NK cells expressing TRAIL are toxic against self hepatocytes in mice. Hepatology 2004, 39:1321-1331.
12. Zou Y, Chen T, Han M, Wang H, Yan W, Song G, Wu Z, Wang X, Zhu C, Luo X, Ning Q: Increased killing of liver NK cells by Fas/Fas ligand and NKG2D/NKG2D ligand contributes to hepatocyte necrosis in virus-induced liver failure. J Immunol 2010, 184:466-475.
13. Dong Z, Wei H, Sun R, Hu Z, Gao B, Tian Z: Involvement of natural killer cells in PolyI:C-induced liver injury. J Hepatol 2004, 41:966-973.
14. Dunn C, Brunetto M, Reynolds G, Christophides T, Kennedy PT, Lampertico P, Das A, Lopes AR, Borrow P, Williams K, Humphreys E, Afford S, Adams DH, Bertoletti A, Maini MK: Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J Exp Med 2007, 204:667-680.
15. Liu M, Mendicino M, Ning Q, Ghanekar A, He W, McGilvray I, Shalev I, Pivato D, Clark DA, Phillips MJ, Levy GA: Cytokine-induced hepatic apoptosis is dependent on FGL2/fibroleukin: the role of Sp1/Sp3 and STAT1/PU.1 composite cis elements. J Immunol 2006, 176:7028-7038.
16. Liu ZX, Govindarajan S, Kaplowitz N: Innate immune system plays a critical role in determining the progression and severity of acetaminophen hepatotoxicity. Gastroenterology 2004, 127:1760-1774.
17. Filer A, Parsonage G, Smith E, Osborne C, Thomas AM, Curnow SJ, Rainger GE, Raza K, Nash GB, Lord J, Salmon M, Buckley CD: Differential survival of leukocyte subsets mediated by synovial, bone marrow, and skin fibroblasts: site-specific versus activation-dependent survival of T cells and neutrophils. Arthritis Rheum 2006, 54:2096-2108.
18. Nazareth MR, Broderick L, Simpson-Abelson MR, Kelleher RJ Jr, Yokota SJ, Bankert RB: Characterization of human lung tumor-associated fibroblasts and their ability to modulate the activation of tumor-associated T cells. J Immunol 2007, 178:5552-5562.
19. Balsamo M, Scordamaglia F, Pietra G, Manzini C, Cantoni C, Boitano M, Queirolo P, Vermi W, Facchetti F, Moretta A, Moretta L, Mingari MC, Vitale M: Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity. Proc Natl Acad Sci U S A 2009, 106:20847-20852.
20. Henderson NC, Iredale JP: Liver fibrosis: cellular mechanisms of progression and resolution. Clin Sci (Lond) 2007, 112:265-280.
21. Jiao J, Friedman SL, Aloman C: Hepatic fibrosis. Curr Opin Gastroenterol 2009, 25:223-229.
22. Holt AP, Haughton EL, Lalor PF, Filer A, Buckley CD, Adams DH: Liver myofibroblasts regulate infiltration and positioning of lymphocytes in human liver. Gastroenterology 2009, 136:705-714.
23. Chinnadurai R, Grakoui A: B7-H4 mediates inhibition of T cell responses by activated murine hepatic stellate cells. Hepatology 2010, 52:2177-2185.
24. Schildberg FA, Wojtalla A, Siegmund SV, Endl E, Diehl L, Abdullah Z, Kurts C, Knolle PA: Murine hepatic stellate cells veto CD8 T cell activation by a CD54-dependent mechanism. Hepatology 2011, 54:262-272.
25. Zhang M, Ye Y, Wang F, Zhu J, Zhao Q, Zheng Y, Gu Y, Xie C, Huang Z, Tai Q, Chong Y, Gao Z: Liver myofibroblasts up-regulate monocyte CD163 expression via PGE2 during hepatitis B induced liver failure. J Transl Med 2014, 12:60.
26. Kuang DM, Peng C, Zhao Q, Wu Y, Zhu LY, Wang J, Yin XY, Li L, Zheng L: Tumor-activated monocytes promote expansion of IL-17-producing CD8+ T cells in hepatocellular carcinoma patients. J Immunol 2010, 185:1544-1549.
27. Pradier A, Passweg J, Villard J, Kindler V: Human bone marrow stromal cells and skin fibroblasts inhibit natural killer cell proliferation and cytotoxic activity. Cell Transplant 2011, 20:681-691.
28. Kurschus FC, Bruno R, Fellows E, Falk CS, Jenne DE: Membrane receptors are not required to deliver granzyme B during killer cell attack. Blood 2005, 105:2049-2058.
29. Magness ST, Bataller R, Yang L, Brenner DA: A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populations. Hepatology 2004, 40:1151-1159.
30. Zhang Z, Zhang S, Zou Z, Shi J, Zhao J, Fan R, Qin E, Li B, Li Z, Xu X, Fu J, Zhang J, Gao B, Tian Z, Wang FS: Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients. Hepatology 2011, 53:73-85.
31. Jeong WI, Park O, Suh YG, Byun JS, Park SY, Choi E, Kim JK, Ko H, Wang H, Miller AM, Gao B: Suppression of innate immunity (natural killer cell/ interferon-gamma) in the advanced stages of liver fibrosis in mice. Hepatology 2011, 53:1342-1351.
32. Luo D, Vanderkerken K, Chen MC, Vermijlen D, Asosingh K, Willems E, Triantis V, Eizirik DL, Kuppen PJ, Wisse E: Rat hepatic natural killer cells (pit cells) express mRNA and protein similar to in vitro interleukin-2 activated spleen natural killer cells. Cell Immunol 2001, 210:41-48.
33. Smith TJ: Insights into the role of fibroblasts in human autoimmune diseases. Clin Exp Immunol 2005, 141:388-397.
34. Zhang M, Wang FL, Zhu JY, Zheng YB, Zhao QY, Gu YR, Zhang Q, Chong YT, Gao ZL: Liver myofibroblasts regulate the phenotype and function of monocytes through soluble factors in cirrhosis. Exp Ther Med 2013, 5:143-149.
35. Radaeva S, Sun R, Jaruga B, Nguyen VT, Tian Z, Gao B: Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2Ddependent and tumor necrosis factor-related apoptosis-inducing liganddependent manners. Gastroenterology 2006, 130:435-452.
36. Melhem A, Muhanna N, Bishara A, Alvarez CE, Ilan Y, Bishara T, Horani A, Nassar M, Friedman SL, Safadi R: Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC. J Hepatol 2006, 45:60-71.
37. Jeong WI, Park O, Radaeva S, Gao B: STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity. Hepatology 2006, 44:1441-1451.
38. Tian Z, Chen Y, Gao B: Natural killer cells in liver disease. Hepatology 2013, 57:1654-1662.
39. Zhang DY, Friedman SL: Fibrosis-dependent mechanisms of hepatocarcinogenesis. Hepatology 2012, 56:769-775.
40. Hirofuji H, Kakumu S, Fuji A, Ohtani Y, Murase K, Tahara H: Natural killer and activated killer activities in chronic liver disease and hepatocellular carcinoma: evidence for a decreased lymphokine-induced activity of effector cells. Clin Exp Immunol 1987, 68:348-356.
41. Notas G, Kisseleva T, Brenner D: NK and NKT cells in liver injury and fibrosis. Clin Immunol 2009, 130:16-26.
42. Sass DA, Shakil AO: Fulminant hepatic failure. Liver Transpl 2005, 11:594-605.
43. Bourbonnais E, Raymond VA, Ethier C, Nguyen BN, El-Leil MS, Meloche S, Bilodeau M: Liver fibrosis protects mice from acute hepatocellular injury. Gastroenterology 2012, 14:130-139. e134.
44. Zhang Z, Zou ZS, Fu JL, Cai L, Jin L, Liu YJ, Wang FS: Severe dendritic cell perturbation is actively involved in the pathogenesis of acute-on-chronic hepatitis B liver failure. J Hepatol 2008, 49:396-406.
45. Terme M, Ullrich E, Delahaye NF, Chaput N, Zitvogel L: Natural killer celldirected therapies: moving from unexpected results to successful strategies. Nat Immunol 2008, 9:486-494.